Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Sweeney

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Intensive Care Medicine|July 14, 2025
Correction: How to approach a patient hospitalized for pneumonia who is not responding to treatment?Pedro Povoa, Luís Coelho, Jordi Carratala, et al.
Intensive Care Medicine|March 28, 2024
Challenges for a broad international implementation of the current severe community-acquired pneumonia guidelinesJorge I F Salluh, Pedro Póvoa, Abi Beane, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 13, 2023
Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position PaperChanu Rhee, Jeffrey R Strich, Kathleen Chiotos, et al.
Open Forum Infectious Diseases|July 12, 2022
Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2Jonathan Fintzi, Tyler Bonnett, Pablo Tebas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2016
Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic SocietyAndre C Kalil, Mark L Metersky, Michael Klompas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 16, 2016
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic SocietyAndre C Kalil, Mark L Metersky, Michael Klompas, et al.
Open Forum Infectious Diseases|May 19, 2023
Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary InfectionsDaniel A Sweeney, Bonifride Tuyishimire, Neera Ahuja, et al.
Medrxiv : the Preprint Server for Health Sciences|November 25, 2020
Microbial context predicts SARS-CoV-2 prevalence in patients and the hospital built environmentClarisse Marotz, Pedro Belda-Ferre, Farhana Ali, et al.
Microbiome|June 9, 2021
SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environmentClarisse Marotz, Pedro Belda-Ferre, Farhana Ali, et al.
The New England Journal of Medicine|May 24, 2020
Remdesivir for the Treatment of Covid-19 - Final ReportJohn H Beigel, Kay M Tomashek, Lori E Dodd, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Intensive Care Medicine|July 14, 2025
Correction: How to approach a patient hospitalized for pneumonia who is not responding to treatment?Pedro Povoa, Luís Coelho, Jordi Carratala, et al.
Intensive Care Medicine|March 28, 2024
Challenges for a broad international implementation of the current severe community-acquired pneumonia guidelinesJorge I F Salluh, Pedro Póvoa, Abi Beane, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 13, 2023
Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position PaperChanu Rhee, Jeffrey R Strich, Kathleen Chiotos, et al.
Open Forum Infectious Diseases|July 12, 2022
Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2Jonathan Fintzi, Tyler Bonnett, Pablo Tebas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2016
Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic SocietyAndre C Kalil, Mark L Metersky, Michael Klompas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 16, 2016
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic SocietyAndre C Kalil, Mark L Metersky, Michael Klompas, et al.
Open Forum Infectious Diseases|May 19, 2023
Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary InfectionsDaniel A Sweeney, Bonifride Tuyishimire, Neera Ahuja, et al.
Medrxiv : the Preprint Server for Health Sciences|November 25, 2020
Microbial context predicts SARS-CoV-2 prevalence in patients and the hospital built environmentClarisse Marotz, Pedro Belda-Ferre, Farhana Ali, et al.
Microbiome|June 9, 2021
SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environmentClarisse Marotz, Pedro Belda-Ferre, Farhana Ali, et al.
The New England Journal of Medicine|May 24, 2020
Remdesivir for the Treatment of Covid-19 - Final ReportJohn H Beigel, Kay M Tomashek, Lori E Dodd, et al.
Pageof 8